This is a working overview of reversed-phase HPLC, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2025-12-20. Anything still debated is marked as such rather than presented as settled.
Lyophilised peptide is normally reconstituted with sterile water or a neutral buffer shortly before use. Because repeated freeze-thaw cycles can degrade the material, dividing a reconstituted solution into single-use aliquots is a common practice. Working solutions are usually kept cold and protected from light. The exact shelf life depends on concentration, buffer composition, and handling, so it is often determined empirically rather than assumed.
Peptide bonds are susceptible to hydrolysis under extreme pH and to enzymatic cleavage if proteases are present. Heat, oxidising agents, and prolonged exposure to light also contribute to loss of material. Aggregation can occur at high concentrations or in certain buffer systems, and it may not be visible to the eye. Storage at -20 C or below is typical for both powder and aliquoted solutions, and desiccation of the powder is preferred.
Dry peptide powder is commonly kept at −20 °C in a desiccated container away from light, a practice that limits moisture uptake and oxidation. Once dissolved, solutions are generally held at 2–8 °C for short periods or frozen at −20 °C or lower for longer storage, with repeated freeze-thaw cycles avoided. Hydrolysis and oxidation are the main degradation routes for peptides in solution, and both accelerate at higher temperature or extreme pH. Published stability data specific to TB-500 are limited, so shelf life should be treated as uncertain.
Identity and purity checks for peptide material typically combine reversed-phase high-performance liquid chromatography with mass measurement, since retention time alone cannot confirm a sequence. Mass measurement verifies the expected molecular mass within instrument tolerance, while chromatographic peak area provides a purity estimate. Anti-doping analysis of urine uses related but more sensitive workflows, sometimes after solid-phase extraction. For research material, batch documentation, certificate content, and independent testing are common points of scrutiny, because supply chains outside pharmaceutical regulation vary widely in the paperwork they provide.
Reconstitution of a lyophilized peptide is normally done with sterile water or a suitable buffer under aseptic conditions. Adding solvent down the vial wall and allowing gentle dissolution instead of vigorous vortexing reduces the chance of aggregation, which can lower the effective concentration of the resulting solution. Concentrated stocks are usually diluted into working buffer shortly before use. Because no standard preparation protocol exists for TB-500 specifically, laboratories adapt general peptide handling practice, and reported results may reflect differing preparation choices.
| Property | Value | Notes |
|---|---|---|
| Purity determination | Reversed-phase HPLC | UV detection commonly at 214 nm |
| Mass confirmation | Mass spectrometry | Compared against theoretical 888.5 Da |
| Powder storage | -20 C or below | Dry and protected from light |
| Reconstituted storage | Aliquoted and frozen | Avoid repeated freeze-thaw cycles |
| Reconstitution solvent | Sterile water or neutral buffer | Avoid extreme pH conditions |
Interest in the compound comes largely from studies of the parent protein, which participates in actin sequestration, cell migration and tissue repair processes. Whether a short fragment reproduces those activities is a separate question that remains open in the published record. Many summaries describe mechanisms by analogy to thymosin beta-4 rather than from direct measurements on the fragment. Claims about activity should be treated as provisional unless a cited study specifies the exact peptide, its purity and the assay used.
TB-500 is a laboratory label applied to a short synthetic peptide that is widely described as a fragment of thymosin beta-4, an actin-binding protein present in most mammalian cells. Suppliers and review articles usually present TB-500 as the N-terminal region of that protein, but the exact sequence attached to the name is not consistent across sources. Some product descriptions list a seven-residue chain; others use the label loosely for the parent protein itself. Because of that variation, any technical discussion of TB-500 needs to state which sequence is meant.
Thymosin beta-4 contains 43 amino acids and has a reported molecular mass near 4963 Da. The short fragment most often associated with the TB-500 label, an acetylated chain beginning LKKTETQ, has a reported mass near 889 Da, so the two are easily separated in analytical work. Mass spectrometry and amino acid analysis can confirm which material is present in a given sample. Statements treating TB-500 and thymosin beta-4 as interchangeable are therefore imprecise, even though the two appear together in much of the same literature.
Published work involving this sequence spans actin-binding assays, cell-migration studies, wound-healing models, and cardiovascular or musculoskeletal experiments. Much of the biological rationale derives from in vitro systems and animal models, and the number of controlled human studies is small. Reported outcomes vary across preparations, doses, and routes, which complicates comparison between studies. Reviews generally describe the evidence base as preliminary rather than settled. Mechanistic explanations are often proposed by analogy to the parent protein rather than demonstrated directly.
TB-500 is a synthetic seven-amino-acid peptide with the sequence LKKTETQ, corresponding to residues 17 through 23 of the protein thymosin beta-4. The N-terminus is typically acetylated in the described form, giving a monoisotopic mass near 888.5 Da and an average mass of about 889 Da. The designation TB-500 is a catalogue label rather than a formal chemical name, and the same sequence appears in the literature under several alternative abbreviations. It is handled as a research reagent rather than a pharmaceutical product.
Laboratory work on thymosin beta-4 describes binding to monomeric actin and effects on cell migration, angiogenesis, and inflammatory signaling in cultured cells. Animal models have examined skin, corneal, and cardiac repair after injury, with outcomes reported mainly in preclinical literature. Most of that evidence concerns the parent protein rather than preparations labelled TB-500, so extrapolation from animal findings to a specific commercial product remains uncertain. Whether the two behave identically in living systems has not been established in controlled human studies.
No major regulatory agency has approved TB-500 for therapeutic use, and it holds no pharmacopoeial monograph. The name appears on the World Anti-Doping Agency prohibited list within the class covering peptide hormones, growth factors, and related substances. Detection in doping control relies on mass spectrometric methods applied to urine, often after preparation steps that concentrate the analyte. Discussion of TB-500 therefore clusters in biochemistry, sports medicine, and anti-doping literature rather than in registered clinical trials.
TB-500 is a synthetic peptide preparation marketed under a name derived from thymosin beta-4, a 43-residue actin-binding protein first isolated from thymus tissue. The full-length protein has a reported molecular mass near 4963 Da, while material sold as TB-500 is often described as a fragment containing the actin-binding motif LKKTETQ. Because suppliers use the name inconsistently, published sources sometimes refer to the same label as a fragment, a synthetic copy, or a related analog. This naming ambiguity complicates direct comparison of reports across studies.
Identity and purity are assessed with a small set of standard techniques. Reverse-phase high-performance liquid chromatography gives a purity estimate from peak area, usually recorded at 214 or 220 nanometers, where the peptide bond absorbs. Mass spectrometry confirms the expected molecular mass and can reveal truncated or oxidized species. Amino acid analysis or tandem mass spectrometry sequencing can verify the sequence itself. Additional quality attributes include water content, residual trifluoroacetic acid carried over from purification, and endotoxin where the material is intended for biological work.
The compound is most often distributed as a lyophilized powder, appearing white to off-white and forming a loose cake or fluffy solid. It is hygroscopic to some degree, so brief exposure to humid air can add water weight and complicate weighing. The peptide dissolves readily in water and in neutral aqueous buffers, and aqueous solubility is generally described as high, well above the concentrations used in typical assays. Some polar organic solvents are also usable, which matters when a concentrated stock is prepared before dilution into buffer.
Pleasure promotes well-being as a positive feeling about what is attractive. Pain, by contrast, diminishes well-being as a negative feeling about what is aversive. Pleasure and pain are closely tied to the brain's reward system, influencing motivation and behavior by reinforcing beneficial actions and discouraging harmful ones. They shape how individuals perceive their lives and interact with their social and physical environments. Pleasure and pain are commonly seen as opposites that counterbalance each other. This view suggests that the negative value of experiencing intense pain can be compensated by the positive value of experiencing intense pleasure. A different perspective argues that their relation is more complex because they influence experience, motivation, and well-being in distinct ways that are not always symmetrical. Following this idea, one view holds that avoiding pain is more important than seeking pleasure. Pleasure and pain are often tied to emotions, which are temporary states of arousal, such as joy, hope, anger, and fear. Emotions include subjective experiences of pleasure and pain alongside other psychological phenomena, such as the evaluative assessment of a situation and a disposition to engage in certain types of behavior. For example, fear evaluates a situation as dangerous and is associated with a behavioral disposition to flee. Additionally, emotions are linked to physiological changes, like sweating, and bodily expressions that signal the emotional state to others.
According to the biogeography of coral species, gene flow cannot be counted on as a dependable source of adaptation as they are very stationary organisms. Also, coral longevity might factor into their adaptivity. However, adaptation to climate change has been demonstrated in many cases, which is usually due to a shift in coral and zooxanthellae genotypes. These shifts in allele frequency have progressed toward more tolerant types of zooxanthellae. Scientists found that a certain scleractinian zooxanthella is becoming more common where sea temperature is high. Symbionts able to tolerate warmer water seem to photosynthesise more slowly, implying an evolutionary trade-off. In the Gulf of Mexico, where sea temperatures are rising, cold-sensitive staghorn and elkhorn coral have shifted in location. Not only have the symbionts and specific species been shown to shift, but there seems to be a certain growth rate favorable to selection. Slower-growing but more heat-tolerant corals have become more common. The changes in temperature and acclimation are complex. Some reefs in current shadows represent a refugium location that will help them adjust to the disparity in the environment even if eventually the temperatures may rise more quickly there than in other locations. This separation of populations by climatic barriers causes a realized niche to shrink greatly in comparison to the old fundamental niche.
Growing numbers of intensive civet "farms" have been established and are operated in Southeast Asia, confining tens of thousands of animals to live in battery cages and be force-fed. "The conditions are awful, much like battery chickens", said Chris Shepherd, deputy regional director of TRAFFIC in Southeast Asia. "The civets are taken from the wild and have to endure horrific conditions. They fight to stay together, but they are separated and have to bear a very poor diet in very small cages. There is a high mortality rate, and for some species of civet, there's a real conservation risk. It is spiraling out of control". The trade in palm civets for the production of kopi luwak may constitute a significant threat to wild populations. In 2013, People for the Ethical Treatment of Animals (PETA) investigators found wild-caught civets on farms in Indonesia and the Philippines. They were deprived of exercise, proper diet, and space. Video footage from the investigation shows abnormal behaviours such as repeated pacing, circling, or biting the bars of their cages. The animals often lose their fur. A BBC investigation revealed similar conditions. Farmers using caged palm civets in north Sumatra confirmed that they supplied kopi luwak beans to exporters whose produce ends up in Europe and Asia. Tony Wild, the coffee executive responsible for bringing kopi luwak to the Western world, has stated he no longer supports using kopi luwak due to animal cruelty and launched a campaign called "Cut the Crap" to halt the use of kopi luwak.
==== Needs of the aquaculture sector in vaccines ==== Aquaculture has an average annual growth rate of 9.2%, however, the success and continued expansion of the fish farming sector is highly dependent on the control of fish pathogens including a wide range of viruses, bacteria, fungi, and parasites. In 2014, it was estimated that these parasites cost the global salmon farming industry up to 400 million Euros. This represents 6–10% of the production value of the affected countries, but it can go up to 20% (Fisheries and Oceans Canada, 2014). Since pathogens quickly spread within a population of cultured fish, their control is vital for the sector. Historically, the use of antibiotics was against bacterial epizootics but the production of animal proteins has to be sustainable, which means that preventive measures that are acceptable from a biological and environmental point of view should be used to keep disease problems in aquaculture at an acceptable level. So, this added to the efficiency of vaccines resulted in an immediate and permanent reduction in the use of antibiotics in the 90s. In the beginning, there were fish immersion vaccines efficient against the vibriosis but proved ineffective against the furunculosis, hence the arrival of injectable vaccines: first water-based and after oil-based, much more efficient (Sommerset, 2005).
Sources: en.wikipedia.org
By comparison, smaller scale civil defense programs were instituted in the United States starting in the 1950s, where schools and other public buildings had basements stocked with non-perishable food supplies, canned water, first aid, and dosimeter and Geiger counter radiation-measuring devices. Many of the locations were given "fallout shelter" designation signs. CONELRAD radio information systems were adopted, whereby the commercial radio sector (later supplemented by the National Emergency Alarm Repeaters) would broadcast on two AM radio frequencies in the event of a Civil Defense (CD) emergency. These two frequencies, 640 and 1240 kHz, were marked with small CD triangles on the tuning dial of radios of the period, as can still be seen on 1950s-vintage radios on online auction sites and museums. A few backyard fallout shelters were built by private individuals. Henry Kissinger's view on tactical nuclear war in his controversial 1957 book Nuclear Weapons and Foreign Policy was that any nuclear weapon exploded in air burst mode that was below 500 kilotons in yield and thus averting serious fallout, may be more decisive and less costly in human lives than a protracted conventional war. A list of targets made by the United States was released sometime during December 2015 by the U.S. National Archives and Records Administration. The language used to describe targets is "designated ground zeros".
=== Targeted protein degradation === Based on the finding that thalidomide and related analogues bind CRBN, heterobifunctional molecules were designed linking thalidomide to ligands for other proteins of interest. These molecules, termed proteolysis targeting chimeras (PROTACs) or protein degraders, recruit CRBN to a protein of interest, leading to its ubiquitination and subsequent degradation. This technology is being explored in clinical trials by a number of biotechnology companies such as Arvinas, C4 Therapeutics, and Kymera Therapeutics.
However, several academic researchers became concerned that AI was no longer pursuing its original goal of creating versatile, fully intelligent machines. Beginning around 2002, they founded the subfield of artificial general intelligence (or "AGI"), which had several well-funded institutions by the 2010s. Deep learning began to dominate industry benchmarks in 2012 and was adopted throughout the field. For many specific tasks, other methods were abandoned. Deep learning's success was based on both hardware improvements (faster computers, graphics processing units, cloud computing) and access to large amounts of data (including curated datasets, such as ImageNet). Neural-network approaches also advanced natural language processing. In 2013, word2vec introduced efficient methods for learning distributed word representations. In 2014–2015, sequence-to-sequence and attention mechanisms advanced neural machine translation. Deep learning's success led to an enormous increase in interest and funding in AI. The amount of machine learning research (measured by total publications) increased by 50% in the years 2015–2019.
=== The New 52 === Following Mogo's destruction, the Guardians tell John Stewart that Mogo's remains appear to be moving toward a particular location, suggesting that Mogo is trying to reform. The Guardians assign Stewart to track it. While traveling, he encounters Fatality, who reveals that Mogo is actually a male and female consciousness that were 'mated' at the core, with John's fragment of Mogo containing the female consciousness that seeks to be reunited with its mate. This prompts Fatality to use her Star Sapphire powers to help the endangered love come together. John and Fatality arrive at the location of Mogo's pieces. They are held prisoner by a space pirate using Mogo's power as the ship's energy beam weapon to attack the planet's core, threatening their lives. John and Fatality attack the space pirate, intending to free Mogo, by sending the space pirate to crash on the planet. John discovers the Guardians' plan to use Mogo. After the events of "War of the Green Lanterns", Mogo reforms into a planet's orbit. The Guardians reveal their plan was to use the size of the reconstituted Mogo and assimilate it into the Third Army, but the plan fails when Mogo destroys the Third Army trying to assimilate it. The villainous First Lantern drains the Green Lantern Corps of their emotions on the planet Oa, but Mogo rescues the Corps by shielding them with dirt and stone, allowing them to escape. When the Green Lantern Corps are transported to Mogo, Mogo creates a scenario in which the Corps is attacked by their doppelgangers.
== History and etymology == Valine was first isolated from casein in 1901 by Hermann Emil Fischer. The name valine comes from its structural similarity to valeric acid, which in turn is named after the plant valerian due to the presence of the acid in the roots of the plant.
Sources: en.wikipedia.org
The lyophilised powder is typically held at -20 C or lower in a dry, dark place. Reconstituted solutions are aliquoted and frozen to avoid repeated freeze-thaw cycles.
Mass spectrometry is the usual confirmatory method because it measures the intact mass. Reversed-phase chromatography is used alongside it to estimate purity.
Not directly. Reported percentages depend on the chromatographic method, detection wavelength, and integration criteria, so the underlying method details matter.
Standard practice is a desiccated container at −20 °C, protected from light and kept sealed between uses. Letting the vial reach room temperature before opening reduces condensation on the powder. Repeated warming and cooling of the whole container is generally avoided.